Cite
HARVARD Citation
Haider, S. et al. (2020). Ustekinumab dose escalation improves clinical responses in refractory Crohn's disease. Therapeutic advances in gastroenterology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Haider, S. et al. (2020). Ustekinumab dose escalation improves clinical responses in refractory Crohn's disease. Therapeutic advances in gastroenterology. p. . [Online].